STERIS plc
NYSE:STE
STERIS plc
Capital Expenditures
STERIS plc
Capital Expenditures Peer Comparison
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
STERIS plc
NYSE:STE
|
Capital Expenditures
-$360.3m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-15%
|
|
Medtronic PLC
NYSE:MDT
|
Capital Expenditures
-$1.6B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-15%
|
|
Trinity Biotech PLC
NASDAQ:TRIB
|
Capital Expenditures
-$2.7m
|
CAGR 3-Years
36%
|
CAGR 5-Years
31%
|
CAGR 10-Years
19%
|
See Also
What is STERIS plc's Capital Expenditures?
Capital Expenditures
-360.3m
USD
Based on the financial report for Mar 31, 2024, STERIS plc's Capital Expenditures amounts to -360.3m USD.
What is STERIS plc's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-15%
Over the last year, the Capital Expenditures growth was 0%. The average annual Capital Expenditures growth rates for STERIS plc have been -15% over the past three years , -14% over the past five years , and -15% over the past ten years .